erotic cues, or in genital or non-genital responses to sexual activity. This can be either lifelong or acquired. Treatment Depending on the cause of the disorder, hormone therapy or a blood-flow enhancing medication, like Viagra, may be appropriate. Bremelanotide (formerly PT-141) is being studied in clinical tests to increase sexual desire in women. In 2014, Palatin, the company developing the drug, announced the beginning of a Phase 3 clinical trial to determine its effectiveness. References See also Erectile dysfunction Female sexual arousal disorder Hypoactive sexual desire disorder Sexual disorders Non-sexuality